SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Silk Road Medical, Inc. - Silk

NEW YORK, Feb. 5, 2021 /PRNewswire/ --A Pomerantz LLP is investigating claims on behalf of investors ofA Silk Road Medical, Inc.("Silk Road" or the "Company")A (NASDAQ: SILK).A Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 7980.The investigation concerns whether Silk Road and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.A  [Click here for information about joining the class action]On January 13, 2021, Silk Road announced in a U.S. Securities and Exchange Commission filing that the Company was "voluntarily recalling 288 units of our ENROUTEA® Transcarotid Stent System, or ENROUTE SDS, based on five reports we received related to the tip of the stent delivery system becoming detached in five TCAR procedures. A These reports were made between September 2020 and January 2021 and we have commenced an investigation into this matter."A 
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Август 2022    »